https://www.selleckchem.com/pr....oducts/fosbretabulin
ALTERTASTE is a prospective study to evaluate changes in taste/flavor perception and food preferences in patients treated with adjuvant or neoadjuvant chemotherapy for breast or colorectal cancer. The study adopts a longitudinal approach. Taste and odor responsiveness, food preferences and habits, emotions elicited by foods, and quality of life will be measured at six-time points before chemotherapy (T, after two cycles (T1, after around 1 month), after four cycles (T2
Like
Comment
Share
